Head and Neck Neoplasms: all 2,403 studies

Page 21 of 25. Open to participants first (559), then studies with results posted, then the rest; newest registration first within each.

• Induction Chemotherapy for Advanced Head and Neck CancerCompletedNCT00959387Phase 2
• Study to Assess Safety and Tolerability of AG013 in Oral Mucositis in Subjects Receiving Induction Chemotherapy for the Treatment of Cancers of the Head and NeckCompletedNCT00938080Phase 1
• Postoperative Concurrent Chemoradiation for Head and Neck Cancer With Multiple Minor RiskTerminatedNCT00937612Not applicable
• S0716 Vandetanib and Docetaxel in Treating Patients With Advanced Solid TumorsWithdrawnNCT00937417Phase 1
• T-cell Based Immunotherapy for Head and Neck CancerWithdrawnNCT00937300Phase 1
• RAD001 (Everolimus) + Docetaxel + Cisplatin as Induction Chemotherapy in Patients With Local-Regional Advanced Head and Neck CancerCompletedNCT00935961Phase 1
• Image Guided Intensity Modulated Reirradiation (IG-IMRT) With Cetuximab for Locoregionally Confined Recurrent Head and Neck Squamous Cell CarcinomaWithdrawnNCT00934518Phase 2
• Functional Imaging of Tumor and Normal TissueTerminatedNCT00933114
• Smoking Cessation Treatment for Head and Neck Cancer PatientsTerminatedNCT00931021Early Phase 1
• Reflux Disease in Head and Neck Cancer Patients Undergoing Radiation TherapyWithdrawnNCT00928161Not applicable
• Endoscopy Screening for Esophageal CancerTerminatedNCT00927446
• Boron Neutron Capture Therapy (BNCT) Combined With Cetuximab in the Treatment of Locally Recurred Head and Neck CancerTerminatedNCT00927147Phase 1/2
• An Open Label Phase I Study to Eval the Safety and Tolerability of a Vaccine (GI-6207) Consisting of Whole, Heat-killed Recombinant Saccharomyces Cerevisiae (Yeast) Genetically Modified to Express CEA Protein in Adults With Metastatic CEA-expressing ...CompletedNCT00924092Phase 1
• NPC Study : TAX + CIS Neoadjuvant in Patients With Loco Regionally Advanced Undifferentiated Carcinoma of Nasopharyngeal Type (UCNT)CompletedNCT00916097Phase 2
• Induction Chemotherapy With Nimotuzumab in Locally Advanced Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00910117Phase 2
• Sunitinib, Cetuximab, and Radiation Therapy in Treating Patients With Locally Advanced or Recurrent Squamous Cell Carcinoma of the Head and NeckTerminatedNCT00906360Phase 1
• Caphosol for the Reduction of Mucositis in Patients Receiving Radiation Therapy for Head and Neck CancerStatus unknownNCT00901732Phase 1/2
• Microsphere-Delivered Cytokines in Increasing Tumor Response in Lymphocytes From Patients With Head and Neck CancerCompletedNCT00899821Not applicable
• Biomarkers in Patients With Head and Neck Cancer and in Healthy VolunteersCompletedNCT00899769
• Biomarkers in Tissue Samples From Patients Who Have Undergone Neck Dissection for Oral CancerWithdrawnNCT00899704
• Protein Expression in Tumor Tissue Samples From Patients With Cancer of the OropharynxCompletedNCT00899340
• Blood Sample Analysis in Predicting Overall Survival in Patients With Recurrent or Metastatic Head and Neck CancerCompletedNCT00898911
• Gene and Protein Expression Patterns in Predicting Response to Cetuximab in Patients With Recurrent and/or Metastatic Head and Neck CancerTerminatedNCT00898742
• DNA Analysis of Tissue Samples From Patients With Head and Neck CancerCompletedNCT00898664
• Biomarkers in Predicting Response to Treatment in Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer Treated With Carboplatin, Paclitaxel, and Radiation TherapyTerminatedNCT00898430
• Collecting and Storing Tissue Samples From Patients With Head and Neck CancerCompletedNCT00898300
• DNA Analysis of Tumor Tissue Samples From Patients With Human Papilloma Virus-Associated Cancer of the OropharynxCompletedNCT00897988
• Growth Factor Levels in the Blood of Patients Undergoing Radiation Therapy for Epithelial CancerCompletedNCT00897793
• Gene Expression Profiles in Predicting Survival of Patients With Head and Neck CancerCompletedNCT00897052
• Study of Proteins in Head and Neck Cancer CellsCompletedNCT00896948
• Immunoreactivity to Cetuximab in Cancer PatientsCompletedNCT00896896
• Blood Proteins in Predicting Treatment Benefit in Patients With Recurrent and/or Metastatic Head and Neck Squamous Cell CancerCompletedNCT00896675
• MRI in Finding Hypoxia in Patients Undergoing Chemo and Radiation for Head and Neck CancerTerminatedNCT00896350Phase 1
• Positron Emission Tomography Imaging With [F-18] FLT Compared to [F-18] FDG in Cancer Patients for Treatment EvaluationWithdrawnNCT00894101Phase 2/3
• An Exploratory, Open Label, Multi-Center, Non-Randomized Study of [F-18]VM4-037CompletedNCT00884520Early Phase 1
• Study Using Pharmacogenetics to Select Treatment for Head and Neck CancerWithdrawnNCT00881114Phase 2
• Chemotherapy, Radiation Therapy, and Cetuximab in Treating Patients With the Head and Neck CancerCompletedNCT00875849Phase 2
• Induction Chemotherapy Followed by Chemoradiation With Cetuximab in Head and Neck CancerCompletedNCT00868491Phase 2
• Xerostomia Pilot Fudan: Acupuncture for Prevention of Radiation-Induced XerostomiaStatus unknownNCT00862550Not applicable
• Radiation Therapy (IMRT) + RAD001 (Everolimus) + Cisplatin for Patients With Head and Neck CancerCompletedNCT00858663Phase 1
• Metronomic Chemotherapy With Tegafur/Uracil for Head and Neck Squamous Cell CarcinomaStatus unknownNCT00855881Phase 2
• Late Phase II Study of Weekly Paclitaxel (BMS-181339) in Patients With Advanced or Recurrent Head and Neck CancerCompletedNCT00855764Phase 2
• A Safety, Efficacy and Pharmacokinetic Study of Siltuximab (CNTO 328) in Participants With Solid TumorsCompletedNCT00841191Phase 1/2
• Developing a Checklist of Lymphedema Symptoms in Patients With Head and Neck CancerCompletedNCT00840814
• Functional Imaging in HNC Undergoing ChemoradiationStatus unknownNCT00837980
• Quality of Life in Patients Undergoing Radiation Therapy for Primary Lung Cancer, Head and Neck Cancer, or Gastrointestinal CancerCompletedNCT00836992
• A Study of the Intratumoural Administration of CAVATAK to Head and Neck Cancer Patients (VLA-X06)TerminatedNCT00832559Phase 1
• Resistance Training During Radiation Therapy for Pharyngeal or Laryngeal CancerCompletedNCT00827164Phase 2
• Topical Cyclosporine vs. Placebo for Epiphora Associated With DocetaxelWithdrawnNCT00824811Phase 2
• Spousal Support in Head and Neck CancerCompletedNCT00824252
• Body Image Functioning Among Surgically Treated Patients With Head and Neck CancerCompletedNCT00824174
• Pharmocokinetic/Pharmacodynamic (PK/PD) Study of the Combination Cetuximab/GefitinibCompletedNCT00820417Phase 1
• Magic Mouthwash Plus Sucralfate Versus Benzydamine Hydrochloride for the Treatment of Radiation-induced MucositisCompletedNCT00814359Phase 3
• The Effect on an Ionic Silver Dressing in Head and Neck Patients With Malignant Fungating WoundStatus unknownNCT00813631Phase 4
• PET Scans in Patients With Head And Neck Cancer Who Are Undergoing 3-Dimensional Conformal Radiation Therapy And Intensity-Modulated Radiation TherapyCompletedNCT00809016Not applicable
• Muscle Composition and Function for Swallowing in Head/Neck Cancer PatientsCompletedNCT00796952Phase 2
• Adjuvant Cetuximab and Chemoradiation in Head and Neck CancerCompletedNCT00791141Phase 2
• Efficacy and Safety Study of SBG vs Placebo in Head and Neck Cancer Patients Undergoing Radiation TherapyCompletedNCT00790322Phase 3
• Validation of FDG-PET Segmentation Tools for Tumor Delineation by Correlation of CT- and FDG-PET Volume Measurements With Histopathology of Nodal Metastases of Head and Neck Carcinomas.Status unknownNCT00782691
• Physiotherapy Treatment for Patients Suffering From Head and Neck CancerCompletedNCT00780312Phase 2
• Comparison of Biomarker Modulation by Inhibition of EGFR and/or SRC FamilyCompletedNCT00779389Phase 1
• TPF Induction With Concomitant Chemoradiation to Treat Patients With Head and Neck CancerStatus unknownNCT00774319Phase 2
• Efficacy of Chemoradiotherapy After Neoadjuvant Cisplatin and Docetaxel in the Nasopharynx CarcinomaCompletedNCT00772681Phase 4
• Study of Nutrition Regimens in Treating Patients With Cancer of the Upper Aerodigestive TractCompletedNCT00765440Phase 3
• TPF Plus Radiotherapy and Cetuximab to Avoid Total Laryngectomy in Patients With Larynx CancerCompletedNCT00765011Phase 2
• Adherence to Swallowing Exercises in Head and Neck CancerStatus unknownNCT00761397
• 3'-Deoxy-3'-[18F] Fluorothymidine and Fludeoxyglucose F 18 PET Scans in Evaluating Response to Cetuximab, Cisplatin, and Radiation Therapy in Patients With Advanced Cancer of the Oropharynx, Larynx, or HypopharynxCompletedNCT00757549Early Phase 1
• Dose Ranging Study to Assess the Safety and Efficacy of SCV-07 for the Delay to Onset of Severe Oral Mucositis in Patients Receiving Chemoradiation Therapy for Head and Neck CancerCompletedNCT00756951Phase 2
• Increasing Physical Activity of Patients With Head and Neck Cancer (I-PAP Study)WithdrawnNCT00756795Not applicable
• Head & Neck Cancer Survivorship: Physical and Functional StatusCompletedNCT00751816
• Cetuximab and Stereotactic Radiation Therapy in Treating Patients With Recurrent Head and Neck Cancer That Cannot Be Removed By SurgeryCompletedNCT00738868Phase 2
• Phase I Study of LBH589 & Erlotinib for Advanced Aerodigestive Tract CancersCompletedNCT00738751Phase 1
• A Phase I Trial of Abraxane, Cisplatin and 5-Fluorouracil Along With Chemoradiotherapy in Advanced Head and Neck CancerCompletedNCT00731380Phase 1
• PET/CT Scan-Guided Watchful Waiting or Neck Dissection of Locally Advanced Lymph Node Metastases in Treating Patients Undergoing Chemotherapy and Radiation Therapy for Primary Head And Neck CancerStatus unknownNCT00720070Phase 3
• TPF Plus Cisplatin and Radiotherapy vs TPF Plus Cetuximab and Radiotherapy to Treat Head and Neck Cancer.CompletedNCT00716391Phase 3
• Incidence and Patterns of Nausea/Vomiting With Combined Chemotherapy and RadiationCompletedNCT00716157
• Neoadjuvant Cetuximab in HNSCC Combined With Curative SurgeryCompletedNCT00714649Phase 1/2
• Chemoradiation Treatment for Head and Neck CancerCompletedNCT00704639Phase 1/2
• Study of Nimotuzumab and Cisplatin/Radiotherapy for Locally Advanced Head and Neck Squamous Cell CancerCompletedNCT00702481Phase 2
• Hyperimmune Colostrum and Oral MucositisStatus unknownNCT00699569Not applicable
• Nutrition and Resistance Training in Head and Neck CancerCompletedNCT00696553Phase 3
• STAT3 DECOY in Head and Neck CancerCompletedNCT00696176Early Phase 1
• Gemcitabine and Carboplatin Followed By Laboratory-Treated T Lymphocytes in Treating Patients With Metastatic or Locally Recurrent Epstein-Barr Virus-Positive Nasopharyngeal CancerStatus unknownNCT00690872Phase 2
• An Expanded Access Programme With Iressa for Patients With Non-Small-Cell Lung Cancer and Cancer of the Head and NeckApproved for marketingNCT00684385
• Postoperative Radiotherapy Plus Iressa or Radiotherapy Plus Cisplatin and Iressa for Advanced Head & Neck CancerCompletedNCT00681967Phase 1
• Photodynamic Therapy Using HPPH in Treating Patients With Dysplasia, Cancer in Situ, or Invasive Cancer of the LarynxCompletedNCT00675233Phase 1
• A Phase I Study of LBH589 (Panobinostat) in Combination With External Beam Radiotherapy for the Treatment of Prostate Cancer, Esophageal Cancer and Head and Neck CancerCompletedNCT00670553Phase 1
• Sexual Behavior in Head and Neck Cancer PatientsStatus unknownNCT00662662
• A Phase I/II Study of Radiation Therapy, Paclitaxel Poliglumex and Cetuximab in Advanced Head and Neck CancerCompletedNCT00660218Phase 1/2
• PET/CT: Role in Detecting Unknown Primary Head and Neck CancerCompletedNCT00656760Not applicable
• Investigation of Pain and Symptom Burden in Patients With Newly Diagnosed Head and Neck CancerCompletedNCT00655005
• Cetuximab, Combination Chemotherapy, and Radiation Therapy in Treating Patients With Newly Diagnosed Stage III or Stage IV Head and Neck Cancer That Cannot Be Removed By SurgeryTerminatedNCT00646659Phase 2
• Trial of E10A in Head and Neck CancerStatus unknownNCT00634595Phase 2
• Bortezomib, Cetuximab, and Radiation Therapy With or Without Cisplatin in Treating Patients With Stage IV Head and Neck CancerCompletedNCT00629226Phase 1
• A Pilot Study of the Use of the DaVinci Robotic System for Otorhinolaryngology-Head and Neck SurgeryStatus unknownNCT00627562Not applicable
• Docetaxel and S-1 Followed By Radiation Therapy and Low-Dose Cisplatin in Treating Patients With Stage III or Stage IV Head and Neck CancerStatus unknownNCT00625937Phase 2
• Cetuximab as Induction Treatment in Head and Neck Squamous Cell Carcinoma (HNSCC)CompletedNCT00623558Phase 2
• Electroacupuncture in Treating Chronic Dry Mouth Caused By Radiation Therapy in Patients With Head and Neck CancerTerminatedNCT00623129Not applicable
• Bortezomib and Cetuximab in Treating Patients With Advanced Solid TumorsCompletedNCT00622674Phase 1
• Bortezomib and Gemcitabine in Treating Older Patients With Advanced Solid TumorsCompletedNCT00620295Phase 1

← Head and Neck Neoplasms overview